How to buy KemPharm (KMPH) shares in the UK

Learn how to easily invest in KemPharm shares.

KemPharm Inc (KMPH) is a publicly traded biotechnology business based in the US. In the week up to 22 September KemPharm shares plunged 13.14% to a closing position of $5.95. However, over the last 12 months, KemPharm's share price has risen by an impressive 62.04% from $9.01. KemPharm is listed on the NASDAQ and employs 24 staff. All prices are listed in US Dollars.

How to buy shares in KemPharm

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: KMPH in this case.
  5. Research KemPharm shares. The platform should provide the latest information available.
  6. Buy your KemPharm shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 100x KemPharm shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £6.37
£1,280.95 total
Capital at risk
IG Share Dealing logo £0 £250 £15.15
£1,289.73 total
Capital at risk
Fineco logo £0 No minimum £12.75
£1,287.33 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £24.70
£1,299.28 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.27
£1,275.85 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £27.11
£1,301.69 total
Capital at risk
Stake logo £0 £50 £6.37
£1,280.95 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £25.43
£1,300.01 total
Capital at risk

Full comparison of share dealing platforms

KemPharm share price (NASDAQ:KMPH)

Use our graph to track the performance of KMPH stocks over time.

KemPharm price performance over time

Historical closes compared with the last close of $14.6

1 week (2022-09-27) 152.60%
1 month (2022-09-02) 160.25%
3 months (2022-07-01) 224.44%
6 months (2022-04-04) 180.23%
1 year (2021-10-04) 62.04%
2 years (2020-10-02) 65.37%
3 years (2019-10-04) 34.19%
5 years (2017-10-04) -76.90%

Is it a good time to buy KemPharm stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
eToro Free Stocks

Invest in KemPharm shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is KemPharm under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

KemPharm's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, KemPharm shares trade at around 21x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, KemPharm's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.

    KemPharm shares at a glance

    Information last updated 2021-06-16.
    Open$15.2
    High$15.25
    Low$14.56
    Close$14.6
    Previous close$15
    Change$-0.4
    Change %-2.6667%
    Volume415,276
    Information last updated 2022-10-03.
    52-week range$4 - $10.799
    50-day moving average$5.847
    200-day moving average$5.7122
    Wall St. target price$19.67
    PE ratio21.15
    Dividend yield$0 (0%)
    Earnings per share (TTM)$0.3

    KemPharm share dividends

    We're not expecting KemPharm to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

    Share price volatility

    Over the last 12 months, KemPharm's shares have ranged in value from as little as $4 up to $10.799. A popular way to gauge a stock's volatility is its "beta".

    Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while KemPharm's is 2.7747. This would suggest that KemPharm's shares are significantly more volatile than the average for this exchange and represent a higher risk.

    To put KemPharm's beta into context you can compare it against those of similar companies.

    Frequently asked questions

    All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

    More guides on Finder

    Ask an Expert

    You are about to post a question on finder.com:

    • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
    • finder.com is a financial comparison and information service, not a bank or product provider
    • We cannot provide you with personal advice or recommendations
    • Your answer might already be waiting – check previous questions below to see if yours has already been asked

    Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

    By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

    Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
    Go to site